Low adjusted-dose acenocoumarol therapy in sickle cell disease: A pilot study

American Journal of Hematology

Volumn 68, Issue 3, 2001, Pages 179-183

  Schnog, J B ^a,b   Kater, A P ^a,b   Mac Gillavry, M R ^a,b   Duits, A J ^a,b   Lard, L R ^a,b   Van Der Dijs, F P L ^a,b   Brandjes, D P M ^a,b   Ten Cate, H ^a,b   Van Statius Eps, L W ^a   Rojer, R A ^a,b  

^a CPRLab   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

Acenocoumarol; Hypercoagulability; Sickle cell disease; Vasoocclusion

Indexed keywords

ACENOCOUMAROL; D DIMER; PLACEBO; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SICKLE CELL ANEMIA; TREATMENT OUTCOME; VEIN OCCLUSION;

ACENOCOUMAROL; ADULT; ANEMIA, SICKLE CELL; ANTICOAGULANTS; ANTIFIBRINOLYTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HUMANS; MIDDLE AGED; PILOT PROJECTS; THROMBOPHILIA; TREATMENT OUTCOME;

EID: 0034779714     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.1175     Document Type: Article

References (33)

1. Sickle cell-disease
2. Pathogenesis and treatment of sickle cell disease
3. Quality of life in children with sickle cell disease in the Amsterdam area
4. Pain, quality of life and coping in sickle cell disease
5. Hemostasis
6. Platelets, coagulation, and fibrinolysis in sickle cell disease: Their possible role in vascular occlusion
7. Vascular occlusion in sickle cell disease: Current concepts and unanswered questions
8. Fragment D-dimer levels: An objective marker of vaso-occlusive crisis and other complications of sickle cell disease
9. Protein S deficiency in sickle cell anemia
10. Elevated D-dimer fragment in sickle cell anemia: Evidence for activation of coagulation during steady state as well as in painful crisis
11. Plasma protein C levels in children with sickle cell disease
12. Plasma tissue factor VII and thrombin-antithrombin levels indicate increased tissue factor activity in sickle-cell patients
13. Blood proteins C and S in sickle cell disease
14. Enhanced thrombin generation in children with sickle cell disease
15. Changes in coagulation and fibrinolysis in patients with sickle cell disease compared with healthy controls
16. Protein C and S activity in sickle cell disease and stroke
17. Prothrombotic changes in children with sickle cell disease: Relationships to cerebrovascular disease and transfusion
18. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease
19. Antiphospholipid antibodies, protein C and S and coagulation changes in sickle cell disease
20. Long term anticoagulation in sickle cell disease: A clinical study
21. Preliminary trial of minidose heparin prophylaxis for painful sickle cell crises
22. Low-intensity oral anticoagulation in sickle cell disease reverses the prethrombotic state: Promises for treatment?
23. The effect of low dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation
24. Monitoring "mini-intensity" anticoagulation with warfarin: Comparison of the prothrombin time using a sensitive thromboplastin with prothrombin fragment F1+2 levels
25. Screening cord blood for hemoglobinopathies and thalassemia by HPLC
26. Cooperative study of sickle cell disease. Acute chest syndrome in sickle cell disease: Clinical presentation and course
27. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography
28. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
29. Impact of bone marrow transplantation for symptomatic sickle cell disease: An interim report
30. New concepts in assessing sickle cell disease severity
31. Pain in sickle cell disease: Rates and risk factors
32. The painful crisis of homozygous sickle cell disease. A study of risk factors